Raymond James Financial recently presented at the Wolfe Wealth Symposium 2026 in New York, featuring CEO Paul Marone Shoukry as a key speaker. Upward revisions to fiscal 2026 earnings estimates by ...
Among the cautious calls, analysts at Erste Group had downgraded the stock’s rating to a Hold from Buy on October 31. While the analysts acknowledged Netflix’s topline and earnings growth, they ...
UroGen Pharma Ltd. (NASDAQ:URGN) is one of the best small-cap biotech stocks to buy according to analysts.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback